Literature DB >> 15034072

Complex role of the IL-4 receptor alpha in a murine model of airway inflammation: expression of the IL-4 receptor alpha on nonlymphoid cells of bone marrow origin contributes to severity of inflammation.

Ann E Kelly-Welch1, Marco E F Melo, Elizabeth Smith, Andrew Q Ford, Christian Haudenschild, Nancy Noben-Trauth, Achsah D Keegan.   

Abstract

Recent studies have suggested the IL-4Ralpha expressed on lung epithelium is necessary for TH2-mediated goblet cell differentiation and mucus hypersecretion in a murine model of allergic lung disease. However, the IL-4Ralpha is expressed on numerous cell types that could contribute to the overall pathology and severity of asthma. The relative role of the receptor on these cells has not yet been conclusively delineated. To dissect the contribution of IL-4Ralpha in the development of pulmonary allergic responses, we generated murine radiation bone marrow (BM) chimeras. BM from IL-4Ralpha(+) or IL-4Ralpha(-) mice was transferred into recipient mice that expressed or lacked IL-4Ralpha. In the absence of IL-4Ralpha in recipient mice, there was no goblet cell metaplasia or mucus hypersecretion in response to OVA, even in the presence of TH2 cells and substantial eosinophilic infiltration. More importantly, we found that expression of the IL-4Ralpha on a nonlymphoid, MHC class II(+), BM-derived cell type contributes to the severity of inflammation and mucus production. These results suggest that IL-4 and IL-13 contribute to the development of allergic inflammation by stimulating a complex interaction between IL-4Ralpha(+) cell types of both bone marrow and non-bone marrow origin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034072     DOI: 10.4049/jimmunol.172.7.4545

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease.

Authors:  Michael J Ripple; Dahui You; Srinivasa Honnegowda; Joseph D Giaimo; Andrew B Sewell; David M Becnel; Stephania A Cormier
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

Review 2.  Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.

Authors:  Douglas A Kuperman; Robert P Schleimer
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.222

3.  Population PK and IgE pharmacodynamic analysis of a fully human monoclonal antibody against IL4 receptor.

Authors:  Tarundeep Kakkar; Cynthia Sung; Leonid Gibiansky; Thuy Vu; Adimoolam Narayanan; Shao-Lee Lin; Michael Vincent; Christopher Banfield; Alex Colbert; Sarah Hoofring; Marta Starcevic; Peiming Ma
Journal:  Pharm Res       Date:  2011-05-21       Impact factor: 4.200

4.  Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome.

Authors:  Zhuo-Qian Zhang; Jing Wang; Zachary Hoy; Achsah Keegan; Samir Bhagwat; Francis Gigliotti; Terry W Wright
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

5.  Enhanced allergic responsiveness after early childhood infection with respiratory viruses: Are long-lived alternatively activated macrophages the missing link?

Authors:  Achsah D Keegan; Kari Ann Shirey; Dayanand Bagdure; Jorge Blanco; Rose M Viscardi; Stefanie N Vogel
Journal:  Pathog Dis       Date:  2016-05-12       Impact factor: 3.166

Review 6.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

7.  TH1-dominant granulomatous pathology does not inhibit fibrosis or cause lethality during murine schistosomiasis.

Authors:  Mosiuoa Leeto; De'Broski R Herbert; Reece Marillier; Anita Schwegmann; Lizette Fick; Frank Brombacher
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  A new mechanism for inhalational priming: IL-4 bypasses innate immune signals.

Authors:  Anna M Dittrich; Hui-Chen Chen; Lan Xu; Patricia Ranney; Sean Connolly; Timur O Yarovinsky; H Kim Bottomly
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome.

Authors:  Sarah M McCormick; Nagaraj Gowda; Jessie X Fang; Nicola M Heller
Journal:  J Biol Chem       Date:  2016-08-09       Impact factor: 5.157

10.  Allergic rhinitis induces anxiety-like behavior and altered social interaction in rodents.

Authors:  Leonardo H Tonelli; Morgan Katz; Colleen E Kovacsics; Todd D Gould; Belzora Joppy; Akina Hoshino; Gloria Hoffman; Hirsh Komarow; Teodor T Postolache
Journal:  Brain Behav Immun       Date:  2009-03-05       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.